Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed Wraith

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|September 29, 2005
Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type ISuresh Vijay, J Ed Wraith
Orphanet Journal of Rare Diseases|September 18, 2008
The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UKDavid Moore, Martin J Connock, Ed Wraith, et al.
Survey of Ophthalmology|January 18, 2006
Mucopolysaccharidoses and the eyeJane L Ashworth, Susmito Biswas, Ed Wraith, et al.
Molecular Genetics and Metabolism|November 21, 2009
Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB miceKia Langford-Smith, Malani Arasaradnam, J Ed Wraith, et al.
Spine|February 28, 2014
Thoracolumbar kyphosis in treated mucopolysaccharidosis 1 (Hurler syndrome)M Naveed Yasin, Raphael Sacho, Neil J Oxborrow, et al.
JIMD Reports|February 23, 2013
Enzyme replacement therapy and extended newborn screening for mucopolysaccharidoses: opinions of treating physiciansDavid J Coman, Ian M Hayes, Veronica Collins, et al.
The Journal of Pediatrics|April 16, 2008
Enzyme replacement therapy for mucopolysaccharidoses: opinions of patients and familiesDavid J Coman, Ian M Hayes, Veronica Collins, et al.
Behavioural Brain Research|February 9, 2010
Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIBMaria M Canal, Fiona L Wilkinson, Jonathan D Cooper, et al.
Stem Cells (Dayton, Ohio)|September 3, 2004
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansionMelissa A Baxter, Robert F Wynn, Simon N Jowitt, et al.
American Journal of Medical Genetics|May 7, 2002
Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S)Olaf A F Bodamer, Heather J Church, Alan Cooper, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Acta Paediatrica (Oslo, Norway : 1992)|September 29, 2005
Clinical presentation and follow-up of patients with the attenuated phenotype of mucopolysaccharidosis type ISuresh Vijay, J Ed Wraith
Orphanet Journal of Rare Diseases|September 18, 2008
The prevalence of and survival in Mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UKDavid Moore, Martin J Connock, Ed Wraith, et al.
Survey of Ophthalmology|January 18, 2006
Mucopolysaccharidoses and the eyeJane L Ashworth, Susmito Biswas, Ed Wraith, et al.
Molecular Genetics and Metabolism|November 21, 2009
Evaluation of heparin cofactor II-thrombin complex as a biomarker on blood spots from mucopolysaccharidosis I, IIIA and IIIB miceKia Langford-Smith, Malani Arasaradnam, J Ed Wraith, et al.
Spine|February 28, 2014
Thoracolumbar kyphosis in treated mucopolysaccharidosis 1 (Hurler syndrome)M Naveed Yasin, Raphael Sacho, Neil J Oxborrow, et al.
JIMD Reports|February 23, 2013
Enzyme replacement therapy and extended newborn screening for mucopolysaccharidoses: opinions of treating physiciansDavid J Coman, Ian M Hayes, Veronica Collins, et al.
The Journal of Pediatrics|April 16, 2008
Enzyme replacement therapy for mucopolysaccharidoses: opinions of patients and familiesDavid J Coman, Ian M Hayes, Veronica Collins, et al.
Behavioural Brain Research|February 9, 2010
Circadian rhythm and suprachiasmatic nucleus alterations in the mouse model of mucopolysaccharidosis IIIBMaria M Canal, Fiona L Wilkinson, Jonathan D Cooper, et al.
Stem Cells (Dayton, Ohio)|September 3, 2004
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansionMelissa A Baxter, Robert F Wynn, Simon N Jowitt, et al.
American Journal of Medical Genetics|May 7, 2002
Variant Gaucher disease characterized by dysmorphic features, absence of cardiovascular involvement, laryngospasm, and compound heterozygosity for a novel mutation (D409H/C16S)Olaf A F Bodamer, Heather J Church, Alan Cooper, et al.
Pageof 3